fbpx

Ramsey Healthcare – FY17 Earnings

Ramsey reported FY17 NPAT in line with guidance at A$543 million, up +12.7% on the same time last year. Revenue was also in line at A$8.7 billion.

All divisions contributed to earnings growth with Australia & Asia as the standout.

You're not a member!  Trial today

Assuming underlying EPS growth of 15% into FY18, we have Ramsey on a 2.2% forward yield, as dividends increase to $1.45 per share.

We view Ramsey as a strong buying opportunity on the next higher low formation, or Algo Engine buy signal.

 

 

Leave a Reply

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2024 Investor Signals

Send our ASX Research to your Inbox

Or start a free thirty day trial for our full service, which includes our ASX Research.